Archiduc Bio: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Archiduc Bio
Largest movements
- Tangible fixed assets +€1.3m
new in 2025: €1.3m
- Receivables within one year +€17,585
up €17,585 (+716%), from €2,455 to €20,040
of which Trade receivables: +€17,545
- Other debts +€1.3m
up €1.3m (+33,296%), from €3,893 to €1.3m
- Gross operating margin +€10,273
up €10,273, from -€497 to €9,775
- Other operating charges +€305
up €305 (+46.4%), from €657 to €961
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
A cash bridge needs two consecutive financial years: one year's result and depreciation cannot explain a change over several years. Pick two years that follow each other.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,484 | €1,310,577 | +€1.3m | +52,662% |
| Fixed assets | 21/28 | - | €1,289,969 | +€1.3m | |
| Tangible fixed assets | 22/27 | - | €1,289,969 | +€1.3m | |
| Plant, machinery and equipment | 23 | - | €1,289,969 | +€1.3m | |
| Current assets | 29/58 | €2,484 | €20,608 | +€18,124 | +730% |
| Amounts receivable within one year | 40/41 | €2,455 | €20,040 | +€17,585 | +716% |
| Trade receivables | 40 | €2,455 | €20,000 | +€17,545 | +715% |
| Other amounts receivable | 41 | - | €40 | +€40 | |
| Cash at bank and in hand | 54/58 | €29 | €568 | +€539 | +1,860% |
| Total equity and liabilities | 10/49 | €2,484 | €1,310,577 | +€1.3m | +52,662% |
| Equity | 10/15 | -€3,543 | €5,271 | +€8,814 | |
| Contributions | 10/11 | €500,000 | €500,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€503,543 | -€494,729 | +€8,814 | +1.8% |
| Amounts payable | 17/49 | €6,027 | €1,305,306 | +€1.3m | +21,557% |
| Amounts payable within one year | 42/48 | €6,027 | €1,305,306 | +€1.3m | +21,557% |
| Trade debts | 44 | - | €5,310 | +€5,310 | |
| Suppliers | 440/4 | - | €5,310 | +€5,310 | |
| Taxes, remuneration and social security | 45 | €2,134 | €0 | -€2,134 | -100% |
| Taxes | 450/3 | €34 | €0 | -€34 | -100% |
| Remuneration and social security | 454/9 | €2,100 | €0 | -€2,100 | -100% |
| Other amounts payable | 47/48 | €3,893 | €1,299,996 | +€1.3m | +33,296% |
| Other operating charges | 640/8 | €657 | €961 | +€305 | +46.4% |
| Gross operating margin | 9900 | -€497 | €9,775 | +€10,273 | |
| Operating profit (loss) | 9901 | -€1,154 | €8,814 | +€9,968 | |
| Financial charges | 65/66B | €42 | €0 | -€42 | -100% |
| Recurring financial charges | 65 | €42 | €0 | -€42 | -100% |
| Profit (loss) for the period before taxes | 9903 | -€1,196 | €8,814 | +€10,010 | |
| Profit (loss) for the period | 9904 | -€1,196 | €8,814 | +€10,010 | |
| Profit (loss) for the period to be appropriated | 9905 | -€1,196 | €8,814 | +€10,010 |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.